Studies On Competition And Antitrust Issues In The Pharmaceutical Industry by Ann-kathrin LehnhausenStudies On Competition And Antitrust Issues In The Pharmaceutical Industry by Ann-kathrin Lehnhausen

Studies On Competition And Antitrust Issues In The Pharmaceutical Industry

byAnn-kathrin Lehnhausen

Paperback | November 22, 2016

Pricing and Purchase Info

$117.50

Earn 588 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug's patent protection has expired. Knowing the characteristics of such anticompetitive strategies helps customers such as health insurance companies to develop effective counter-strategies.
Ann-Kathrin Lehnhausen, M.Sc. in Business Administration and M.A. in Economics, worked at Justus-Liebig-University Giessen as teaching asssistant during her studies. After her graduation she started working as junior sales manager, responsible for API Exports, at a pharmaceutical company, where she combines her interest in economics wi...
Loading
Title:Studies On Competition And Antitrust Issues In The Pharmaceutical IndustryFormat:PaperbackDimensions:85 pages, 21 × 14.8 × 0.02 inPublished:November 22, 2016Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3658165502

ISBN - 13:9783658165505

Reviews

Table of Contents

Overview of Antitrust and Competition Issues.- Vertical Restraints under Parallel Trade.- Competitive Restraints under Reference Pricing.